December 27, 2022
The Japanese Medical and Dental Practitioners for the Improvement of Medical Care (Hodanren) on December 23 issued a statement on the FY2023 drug re-pricing, arguing that the planned special measure to maintain the prices of on-patent medicines is problematic. For...read more